Line Voldstad
PARTNER Line Voldstad, heads DLA Piper Norway’s procurement team and specializes in public procurement, EEA/regulatory and competition law. She assists i.a. life science companies; both on a national and international basis in regulatory and competition law matters. Her experience include advising several pharmaceutical and/or life science companies in procurement processes, with i.a. regulatory and marketing issues, including regulatory framework in relation to collection and handling of health data, clinical studies, home treatment and possible set-up, and standard operating procedures to comply with Norwegian law and ethical rules; competition law issues, including accessibility of data and information sharing. She has significant …
PARTNER
Line Voldstad, heads DLA Piper Norway’s procurement team and specializes in public procurement, EEA/regulatory and competition law. She assists i.a. life science companies; both on a national and international basis in regulatory and competition law matters. Her experience include advising several pharmaceutical and/or life science companies in procurement processes, with i.a. regulatory and marketing issues, including regulatory framework in relation to collection and handling of health data, clinical studies, home treatment and possible set-up, and standard operating procedures to comply with Norwegian law and ethical rules; competition law issues, including accessibility of data and information sharing. She has significant experience from a vast range of cross border legal advice coordination and projects, including competition law analysis and advice relating to pharmaceutical patents and patent litigation as part of a cross border team before the Commission, General Court, and subsequently the European Court of Justice.
See more
Line Voldstad, heads DLA Piper Norway’s procurement team and specializes in public procurement, EEA/regulatory and competition law. She assists i.a. life science companies; both on a national and international basis in regulatory and competition law matters. Her experience include advising several pharmaceutical and/or life science companies in procurement processes, with i.a. regulatory and marketing issues, including regulatory framework in relation to collection and handling of health data, clinical studies, home treatment and possible set-up, and standard operating procedures to comply with Norwegian law and ethical rules; competition law issues, including accessibility of data and information sharing. She has significant experience from a vast range of cross border legal advice coordination and projects, including competition law analysis and advice relating to pharmaceutical patents and patent litigation as part of a cross border team before the Commission, General Court, and subsequently the European Court of Justice.
